PRODUCTS

Morpheus®

Best-In-Class Handling

Biogennix’s flagship product brand, Morpheus, is an advanced bone graft product consisting of a moldable suspension of 1-2mm TrelCor® granules in a rapidly absorbing, organic binder.  Based on TrelCor technology, the granules provide enhanced bone formation due to the combination of a nanocrystalline surface with an HCA composition and interconnected pore structure that emulate human cancellous bone.

Morpheus bone graft product is a robust graft material that provides optimal handling characteristics during intraoperative placement. Morpheus is moldable, cohesive, mixable with autogenous bone, and leaves minimal residual material on surgical gloves following handling. The binder’s resistance to breakdown and irrigation facilitate secure placement and stabilization of the graft mass. It is then rapidly absorbed leaving behind the porous TrelCor granules, which are resorbed, remodeled, and replaced with bone over the next 6-12 months.

Morpheus Logo

Configuration: Moldable

Chemistry: Nanocrystalline hydroxycarbanoapatite (HCA) / calcium carbonate (CC) granules in organic binder

Architecture: Biomimetic structure similar to cancellous bone; interconnected porosity

Granule Pore Size: 500 microns (µm)

Binder Absorption Profile: 1-2 days

Granule Resorption Profile: 6-12 months

Storage and Handling: Room temperature, no reconstitution required

Morpheus Logo

Configuration: Moldable

Chemistry: Nanocrystalline hydroxycarbanoapatite (HCA) / calcium carbonate (CC) granules in organic binder

Architecture: Biomimetic structure similar to cancellous bone; interconnected porosity

Granule Pore Size: 500 microns (µm)

Binder Absorption Profile: 1-2 days

Granule Resorption Profile: 6-12 months

Storage and Handling: Room temperature, no reconstitution required

Morpheus DIFFERENCE

Unlike other porous ceramic materials, Morpheus provides the surgeon an advanced bone graft that is actively involved in the bone healing process

TrelCor Technology

  • Nanocrystalline structure provides an optimal surface for cell attachment and bone regeneration
  • HCA composition closely mimics human bone mineral and provides an enhanced osteoconductive surface
  • Biomimetic pore structure similar to cancellous bone allows for bone in-growth throughout the implant and results in a robust scaffold that resists crushing during intraoperative handling

Excellent Handling

  • Firm consistency that is moldable, cohesive, and mixable with autograft
  • Stays in place, holds it shape, and resists irrigation
  • Leaves minimal residue on gloves
  • No hydration required
Back To Top